Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer.
Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer. PATRICK FARRELL Miami Herald File Photo
Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer. PATRICK FARRELL Miami Herald File Photo

Business

Vigilant Biosciences cleared to launch its oral cancer test across Europe

May 04, 2016 9:45 AM

  Comments  

Videos